NIOX Group PLC (NIOX)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

67.20p

Buy

69.20p

arrow-up1.00p (+1.48%)

Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.

Income statement

20232024
37m42m
27m30m
5m8m
12.5018.42
11m4m
9m12m
Sales, General and administrative20m20m
Interest expenses100,000100,000
Provision for income taxes-5m4m
Operating expenses22m23m
Income before taxes4m8m
Net income available to common shareholders11m4m
0.02550.0088
Net interest income600,000700,000
Advertising and promotion--
Net investment income, net-1m-500,000
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.02380.0083
Free cash flow per share0.02360.0266
Book value/share0.19220.2055
Debt equity ratio0.0059670.013445

Balance sheet

20232024
Current assets34m21m
Current liabilities7m8m
Total capital84m60m
Total debt1m2m
Total equity84m60m
Total non current liabilities--
Loans--
Total assets92m68m
Total liabilities--
Cash and cash equivalents20m11m
Common stock421m398m

Cash flow

20232024
Cash at beginning of period19m20m
Cash dividends paid-10m-4m
11m16m
Investments (gains) losses-300,000-1m
20m11m
Net income--
12m17m
-300,000-1m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.